Pioneering therapeutics to turn every IVF attempt into a success story
Ovo Labs is developing therapeutics that boost egg quality to enhance IVF success. It is developing three egg rejuvenation therapeutics through pre-clinical development. Together, these therapeutics have the potential to increase IVF success rates by 20-30% for women below 35 and by 3-5 times for women aged 35-45.
Prof. Melina Schuh Dr Agata Zielinska Dr Oleksandr Yagensky
Genetics and Platform Technologies
